Literature DB >> 29803552

Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction.

Yogesh N V Reddy1, Thomas P Olson1, Masaru Obokata1, Vojtech Melenovsky2, Barry A Borlaug3.   

Abstract

OBJECTIVES: This study sought to define the invasive hemodynamic correlates of peak oxygen consumption (Vo2) in both supine and upright exercise in heart failure with preserved ejection fraction (HFpEF) and evaluate its diagnostic role as a method to discriminate HFpEF from noncardiac etiologies of dyspnea (NCD).
BACKGROUND: Peak Vo2 is depressed in patients with HFpEF. The hemodynamic correlates of reduced peak Vo2 and its role in the clinical evaluation of HFpEF are unclear.
METHODS: Consecutive patients with dyspnea and normal EF (N = 206) undergoing both noninvasive upright and invasive supine cardiopulmonary exercise testing were examined. Patients with invasively verified HFpEF were compared with those with NCD.
RESULTS: Compared with NCD (n = 72), HFpEF patients (n = 134) displayed lower peak Vo2 during upright and supine exercise. Left heart filling pressures during exercise were inversely correlated with peak Vo2 in HFpEF, even after accounting for known determinants of O2 transport according to the Fick principle. Very low upright peak Vo2 (<14 ml/kg/min) discriminated HFpEF from NCD with excellent specificity (91%) but poor sensitivity (50%). Preserved peak Vo2 (>20 ml/kg/min) excluded HFpEF with high sensitivity (90%) but had poor specificity (49%). Intermediate peak Vo2 cutoff points were associated with substantial overlap between cases and NCD.
CONCLUSIONS: Elevated cardiac filling pressure during exercise is independently correlated with reduced exercise capacity in HFpEF, irrespective of body position, emphasizing its importance as a novel therapeutic target. Noninvasive cardiopulmonary testing discriminates HFpEF and NCD at high and low values, but additional testing is required for patients with intermediate peak Vo2.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HFpEF; diagnosis; exercise; heart failure; hemodynamics

Mesh:

Year:  2018        PMID: 29803552      PMCID: PMC6076329          DOI: 10.1016/j.jchf.2018.03.003

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  47 in total

1.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

Review 2.  Executive Summary of the SCAI/HFSA Clinical Expert Consensus Document on the Use of Invasive Hemodynamics for the Diagnosis and Management of Cardiovascular Disease.

Authors:  Michael M Givertz; James C Fang; Paul Sorajja; Vivian Dimas; Paul R Forfia; Navin K Kapur; Morton J Kern; Srihari S Naidu; Barry A Borlaug
Journal:  J Card Fail       Date:  2017-04-25       Impact factor: 5.712

3.  Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction.

Authors:  Mark J Haykowsky; Peter H Brubaker; Jerry M John; Kathryn P Stewart; Timothy M Morgan; Dalane W Kitzman
Journal:  J Am Coll Cardiol       Date:  2011-07-12       Impact factor: 24.094

4.  The invasive cardiopulmonary exercise test.

Authors:  Bradley A Maron; Barbara A Cockrill; Aaron B Waxman; David M Systrom
Journal:  Circulation       Date:  2013-03-12       Impact factor: 29.690

5.  Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction.

Authors:  Bishnu P Dhakal; Rajeev Malhotra; Ryan M Murphy; Paul P Pappagianopoulos; Aaron L Baggish; Rory B Weiner; Nicholas E Houstis; Aaron S Eisman; Stacyann S Hough; Gregory D Lewis
Journal:  Circ Heart Fail       Date:  2014-10-24       Impact factor: 8.790

6.  Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug; Thomas P Olson; Carolyn S P Lam; Kelly S Flood; Amir Lerman; Bruce D Johnson; Margaret M Redfield
Journal:  J Am Coll Cardiol       Date:  2010-09-07       Impact factor: 24.094

Review 7.  INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design.

Authors:  Yogesh N V Reddy; Gregory D Lewis; Sanjiv J Shah; Martin LeWinter; Marc Semigran; Victor G Davila-Roman; Kevin Anstrom; Adrian Hernandez; Eugene Braunwald; Margaret M Redfield; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2017-05       Impact factor: 8.790

8.  Percutaneous Pericardial Resection: A Novel Potential Treatment for Heart Failure With Preserved Ejection Fraction.

Authors:  Barry A Borlaug; Rickey E Carter; Vojtech Melenovsky; Christopher V DeSimone; Prakriti Gaba; Ammar Killu; Niyada Naksuk; Lilach Lerman; Samuel J Asirvatham
Journal:  Circ Heart Fail       Date:  2017-04       Impact factor: 8.790

9.  Hemodynamic determinants of dyspnea improvement in acute decompensated heart failure.

Authors:  Amir Solomonica; Andrew J Burger; Doron Aronson
Journal:  Circ Heart Fail       Date:  2012-11-14       Impact factor: 8.790

10.  Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.

Authors:  Michael R Zile; Barbro Kjellstrom; Tom Bennett; Yong Cho; Catalin F Baicu; Mark F Aaron; William T Abraham; Robert C Bourge; Fred J Kueffer
Journal:  Circ Heart Fail       Date:  2013-03-20       Impact factor: 8.790

View more
  45 in total

1.  Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial.

Authors:  Barry A Borlaug; Kevin J Anstrom; Gregory D Lewis; Sanjiv J Shah; James A Levine; Gabe A Koepp; Michael M Givertz; G Michael Felker; Martin M LeWinter; Douglas L Mann; Kenneth B Margulies; Andrew L Smith; W H Wilson Tang; David J Whellan; Horng H Chen; Victor G Davila-Roman; Steven McNulty; Patrice Desvigne-Nickens; Adrian F Hernandez; Eugene Braunwald; Margaret M Redfield
Journal:  JAMA       Date:  2018-11-06       Impact factor: 56.272

2.  Pericardiotomy Enhances Left Ventricular Diastolic Reserve With Volume Loading in Humans.

Authors:  Barry A Borlaug; Hartzell V Schaff; Alberto Pochettino; Dawn M Pedrotty; Samuel J Asirvatham; Martin D Abel; Rickey E Carter; William J Mauermann
Journal:  Circulation       Date:  2018-11-13       Impact factor: 29.690

Review 3.  The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction: What Do We Want from Imaging?

Authors:  Masaru Obokata; Yogesh N V Reddy; Barry A Borlaug
Journal:  Heart Fail Clin       Date:  2019-02-02       Impact factor: 3.179

Review 4.  Heart Failure With Preserved Ejection Fraction In Perspective.

Authors:  Marc A Pfeffer; Amil M Shah; Barry A Borlaug
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

5.  The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure With Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Masaru Obokata; Katlyn E Koepp; Alexander C Egbe; Brandon Wiley; Barry A Borlaug
Journal:  Circ Res       Date:  2019-01-18       Impact factor: 17.367

6.  The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction.

Authors:  Yogesh N V Reddy; Masaru Obokata; Brandon Wiley; Katlyn E Koepp; Caitlin C Jorgenson; Alexander Egbe; Vojtech Melenovsky; Rickey E Carter; Barry A Borlaug
Journal:  Eur Heart J       Date:  2019-12-01       Impact factor: 29.983

Review 7.  Performance and Interpretation of Invasive Hemodynamic Exercise Testing.

Authors:  C Charles Jain; Barry A Borlaug
Journal:  Chest       Date:  2020-05-28       Impact factor: 9.410

8.  Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction.

Authors:  Jennifer E Ho; Margaret M Redfield; Gregory D Lewis; Walter J Paulus; Carolyn S P Lam
Journal:  Circulation       Date:  2020-11-02       Impact factor: 29.690

9.  The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.

Authors:  Masaru Obokata; Garvan C Kane; Yogesh N V Reddy; Vojtech Melenovsky; Thomas P Olson; Petr Jarolim; Barry A Borlaug
Journal:  Eur Heart J       Date:  2019-12-01       Impact factor: 29.983

Review 10.  Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction.

Authors:  Yen-Chun Lai; Longfei Wang; Mark T Gladwin
Journal:  J Physiol       Date:  2018-12-30       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.